SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

14 May 2025 07:00

RNS Number : 5363I
TP ICAP Group plc
14 May 2025
 

TP ICAP GROUP PLC (the "Group")

 

14 May 2025

 

Trading Update for the three months ended 31 March 2025

 

Note: comparisons are to Q1 2024 unless otherwise indicated; all percentage movements are in constant currency[1].

Total revenue grew 10% to £629m, the best quarter ever registered by the Group, benefiting from a period of heightened market volatility which was driven by the uncertainty of U.S. trade policies.

Global Broking revenue increased 14%, with the division performing strongly across all asset classes, capitalising on the exceptionally favourable market conditions.

Liquidnet delivered another strong quarter, with revenue up 16%.

Energy & Commodities (E&C) revenue was unchanged, in line with our expectations, reflecting a competitive hiring market for brokers in 2024.

Following a record performance in Q1 2024, including one-off revenue, Parameta Solutions revenue increased by 6% in Q1 2025.

Outlook

The Board remains comfortable with current market expectations for 2025 adjusted EBIT, following a strong first quarter performance and despite the recent weakening of the U.S. Dollar[2].

Approximately 60% of Group revenues and 40% of Group costs are USD-denominated.

Business update

 

At our full year 2024 results, announced on 11 March 2025, the Group stated that should it proceed with a potential minority listing of Parameta Solutions, this could occur as early as Q2 2025.

Following the recent market turbulence, the Board will now keep under review the appropriate timing for any potential minority listing.

2025 Annual General Meeting

The Group will host its Annual General Meeting today, Wednesday 14 May 2025, at 2.15pm (BST) at the offices of Allen & Overy Shearman Sterling LLP, One Bishops Square, London, E1 6AD.

2025 half year results

The Group will report its results for the six months ended 30 June 2025 on 6 August 2025.

 

Forward looking statements

This document contains forward looking statements with respect to the financial condition, results and business of the Company. By their nature, forward looking statements involve risk and uncertainty and there may be subsequent variations to estimates. The Company's actual future results may differ materially from the results expressed or implied in these forward-looking statements.

 

Enquiries

Group Company Secretary Vicky Hart

Email: companysecretarial@tpicap.com

 

Analysts and investors Dominic Lagan Direct: +44 (0) 20 3933 0447

Email: dominic.lagan@tpicap.com  

Media Richard Newman Direct: +44 (0) 7469 039 307

Email: richard.newman@tpicap.com

  

About TP ICAP

· TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

· It is the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

· We operate from more than 60 offices across 28 countries, supporting brokers with award-winning and market-leading technology.

 

Further information on the company and its activities is available on the Company's website:

www.tpicap.com.

 


[1] Note the average GBP/ U.S. Dollar exchange rate was $1.26 in Q1 2024 and Q1 2025. Consequently, movements on a constant currency basis and on a reported basis are the same.

 

[2] On 30th April the Sterling to U.S. Dollar rate was $1.34, compared with an average of $1.28 for full year 2024.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVAETIVLIE
Date   Source Headline
23rd Apr 20204:30 pmRNSHolding(s) in Company
17th Apr 202012:09 pmRNSAnnual Financial Report
1st Apr 20207:00 amRNSDirector/PDMR Shareholding - Replacement
24th Mar 20207:00 amRNSDirectorate Change
20th Mar 20207:00 amRNSHolding(s) in Company
17th Mar 202010:52 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSFinal Results
6th Mar 20207:00 amRNSDirectorate Change
18th Feb 20202:54 pmRNSHolding(s) in Company
18th Feb 20207:00 amRNSDirectorate Change
23rd Jan 20205:33 pmRNSHolding(s) in Company
16th Jan 20202:34 pmRNSHolding(s) in Company
24th Dec 20197:00 amRNSProposed acquisition of Louis Capital
23rd Dec 20197:00 amRNSIntroduction of a new Jersey incorporated HoldCo
11th Dec 20199:29 amRNSHolding(s) in Company
1st Nov 20191:58 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSTrading Statement
31st Oct 20197:00 amRNSTotal Voting Rights
18th Oct 20197:10 amRNSDirectorate Change
11th Oct 20197:00 amRNSSettlement of FCA Investigation
7th Oct 20198:50 amRNSHolding(s) in Company
27th Sep 20197:00 amRNSDirector Declaration and Board Change
19th Sep 20192:22 pmRNSHolding(s) in Company
16th Sep 20194:13 pmRNSAcquisition
14th Aug 20194:41 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSFinancial and Interim Management Report
28th Jun 20193:26 pmRNSDirector/PDMR Shareholding
6th Jun 20194:08 pmRNSDirector/PDMR Shareholding
28th May 20191:20 pmRNSPublication of Final Terms
24th May 201910:38 amRNSResult of Tender Offer
16th May 201910:58 amRNSTender Offer
15th May 20195:45 pmRNSPublication of a Prospectus
15th May 20194:41 pmRNSConfirmation of Richard Berliand as Chairman
15th May 20194:37 pmRNSResult of AGM
15th May 20197:00 amRNSAGM Statement and Trading Update
12th Apr 20191:17 pmRNSDirector/PDMR Shareholding
3rd Apr 20195:35 pmRNSDirector/PDMR Shareholding
19th Mar 20197:01 amRNSConfirmation of Director Appointment
19th Mar 20197:00 amRNSFinal Results
1st Mar 20192:58 pmRNSHolding(s) in Company
28th Feb 20192:22 pmRNSHolding(s) in Company
21st Feb 20194:14 pmRNSHolding(s) in Company
7th Feb 20194:15 pmRNSHolding(s) in Company
29th Jan 20192:13 pmRNSStatement re Press Release
28th Jan 20195:00 pmRNSHolding(s) in Company
25th Jan 20197:00 amRNSBoard Committee Changes
17th Jan 20199:17 amRNSHolding(s) in Company
14th Dec 20181:52 pmRNSHolding(s) in Company
14th Dec 20187:00 amRNSDirectorate Change
13th Dec 20189:22 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.